Article Details

The Biohaven Pharmaceutical (BHVN) Given a $65.00 Price Target at Piper Jaffray Companies

Retrieved on: 2019-05-31 04:54:00

Tags for this article:

Click the tags to see associated articles and topics

The Biohaven Pharmaceutical (BHVN) Given a $65.00 Price Target at Piper Jaffray Companies. View article details on hiswai:

Excerpt

<div><b>Sofinnova Ventures</b> Inc acquired a new position in shares of Biohaven Pharmaceutical during the third quarter worth about $4,996,000. Sphera Funds ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up